	US 12,421,218 B2
	Substituted pyrazine-carboxamide derivatives
Roland Pfau, Mittelbiberach (DE); Georg Dahmann, Biberach (DE); Johann Faustus Du Hoffmann, Biberach an der Riss (DE); Kai Gerlach, Mittelbiberach (DE); Riccardo Giovaninni, Biberach an der Riss (DE); Christoph Hohn, Freiburg (DE); Stefan Just, Biberach an der Riss (DE); Thorsten Lehmann, Biberach (DE); Anton Pekcec, Biberach (DE); Stefan Peters, Biberach an der Riss (DE); Julia Schlichtiger, Biberach (DE); Heiko Sommer, Warthausen (DE); Christian Specker, Hochdorf (DE); and Dieter Wiedenmayer, Biberach an der Riss (DE)
Assigned to Boehringer Ingelheim International GmbH, Ingelheim am Rhein (DE)
Filed by Boehringer Ingelheim International GmbH, Ingelheim am Rhein (DE)
Filed on Aug. 14, 2024, as Appl. No. 18/804,311.
Application 18/804,311 is a continuation of application No. 18/384,393, filed on Oct. 27, 2023.
Claims priority of application No. 22204281 (EP), filed on Oct. 28, 2022.
Prior Publication US 2024/0417394 A1, Dec. 19, 2024
Int. Cl. C07D 403/12 (2006.01); A61P 25/18 (2006.01); C07D 405/14 (2006.01)

CPC C07D 405/14 (2013.01) [A61P 25/18 (2018.01); C07D 403/12 (2013.01)]

14 Claims

1. A compound selected from the group consisting of

or a pharmaceutically acceptable salt thereof.